4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-23-000029
President and CEO sold 33,815 shares at an average $30.08 ($1,017,243)
- President and CEO acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Watts Ryan J. · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-13 | Sale : show line 1 in the form | −8,815 | $30.09 | $265,243 | 2,239,913 | I |
| 2023-02-13 | Exercise or conversion : show line 2 in the form | +25,000 | $0.68 | $17,000 | 2,264,913 | I |
| 2023-02-13 | Sale : show line 3 in the form | −25,000 | $30.08 | $752,000 | 2,239,913 | I |
| Open-market sales · 33,815 sh · avg $30.08 · $1,017,243 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-13 | Exercise or conversion : show line 4 in the form Stock Option (right to buy) | −25,000 | 1,195,617 | D |
Loading xslF345X03/wf-form4_167650567156375.xml…